Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-06-03
1989-10-03
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514304, 548372, 546112, 546126, C07D45112, C07D45114, A61K 31395
Patent
active
048717444
ABSTRACT:
Compounds of formula (I) and pharmaceutically acceptable salts thereof; ##STR1## wherein L is NH or O;
REFERENCES:
J. L. G. Nilsson et al., "Some Quinuclidine Derivatives with Potential Antimalarial Activity", Acta Pharm. Suecica, 5, pp. 71-76 (1968) [Nilsson et al.]
"Serotonin Antagonists--Too Much Hype?", SCRIP, No. 1215, p. 26 (Jun. 19, 1987) [SCRIP I].
"Glaxo's GR-38032F in Emesis CT Results", SCRIP, No. 1219, p. 24 (Jul. 3, 1987) [SCRIP II].
J. Lars et al., "Some Quinuclidine Derivatives with Potential Antimalarial Activity", Acta Pharm. Suecica, 5, pp. 71-76 (1968).
Joiner Karen A.
King Francis D.
Barr David K.
Beecham Group p.l.c.
Evans Emily A.
Haley, Jr. James F.
Rotman Alan L.
LandOfFree
Certain 2,3-dihydro-indole-1-carboxamido-N-[8-azabicyclo(3.2.1)o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain 2,3-dihydro-indole-1-carboxamido-N-[8-azabicyclo(3.2.1)o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain 2,3-dihydro-indole-1-carboxamido-N-[8-azabicyclo(3.2.1)o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-664552